CHEMICAL SYNTHESIS, ABSOLUTE-CONFIGURATION, AND STEREOCHEMISTRY OF FORMATION OF 10-HYDROXYWARFARIN - A MAJOR OXIDATIVE METABOLITE OF (+)-(R)-WARFARIN FROM HEPATIC-MICROSOMAL PREPARATIONS

被引:27
作者
LAWRENCE, RF [1 ]
RETTIE, AE [1 ]
EDDY, AC [1 ]
TRAGER, WF [1 ]
机构
[1] UNIV WASHINGTON,DEPT SURG,SEATTLE,WA 98195
关键词
10‐hydroxywarfarin; human liver; P‐450IIIA family;
D O I
10.1002/chir.530020207
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of a diastereomerically pure 10‐hydroxywarfarin [4‐hydroxy‐3‐(2‐hydroxy‐3‐oxo‐1‐phenylbutyl)‐2H‐1‐benzopyran‐2‐one] was accomplished in three steps from racemic warfarin. The relative configuration of the synthetic product was established by conversion to a cyclic derivative followed by NMR and X‐ray diffraction analysis. Absolute stereochemistry was determined by enzymatic conversion of either of the pure enantiomers of warfarin to a 10‐hydroxy metabolite of known relative configuration. Metabolic formation of 10‐hydroxywarfarin was studied using hepatic microsomal preparations from female rats and man. The formation of 10‐hydroxywarfarin catalyzed by hepatic microsomes from both dexamethasone‐treated rats and man was highly stereoselective [(R)/(S): 3.4–9.0] for (R)‐warfarin. In contrast, little stereoselectivity was observed in reactions catalyzed by untreated rat liver microsomes. The resultant stereochemistry at the site of oxidation was also found to be highly dependent on substrate stereochemistry. (R)‐Warfarin gave (9R;10S)‐10‐hydroxywarfarin with only a trace of the (9R;10R) isomer irrespective of which enzyme preparation was used for catalysis, while (S)‐warfarin gave (9S;10R)‐10‐hydroxywarfarin with only a trace of the (9S;10S) isomer, again irrespective of which enzyme preparation was used for catalysis. Copyright © 1990 Wiley‐Liss, Inc.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 25 条
[1]  
Black T. H., 1983, ALDRICHIM ACTA, V16, P3
[2]   SUBSTRATE PROBES FOR THE MECHANISM OF AROMATIC HYDROXYLATION CATALYZED BY CYTOCHROME-P-450 - SELECTIVELY DEUTERATED ANALOGS OF WARFARIN [J].
BUSH, ED ;
TRAGER, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (08) :992-996
[3]   A SENSITIVE AND SPECIFIC STABLE ISOTOPE ASSAY FOR WARFARIN AND ITS METABOLITES [J].
BUSH, ED ;
LOW, LK ;
TRAGER, WF .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (07) :395-398
[4]   ABSOLUTE CONFIGURATIONS OF FOUR WARFARIN ALCOHOLS [J].
CHAN, KK ;
TRAGER, WF ;
LEWIS, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (12) :1265-&
[5]   DEGRADATION OF RAT HEPATIC CYTOCHROME-P-450 HEME BY 3,5-DICARBETHOXY-2,6-DIMETHYL-4-ETHYL-1,4-DIHYDROPYRIDINE TO IRREVERSIBLY BOUND PROTEIN ADDUCTS [J].
CORREIA, MA ;
DECKER, C ;
SUGIYAMA, K ;
CALDERA, P ;
BORNHEIM, L ;
WRIGHTON, SA ;
RETTIE, AE ;
TRAGER, WF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1987, 258 (02) :436-451
[6]   NEW WARFARIN METABOLITE - STRUCTURE AND FUNCTION [J].
FASCO, MJ ;
DYMERSKI, PP ;
WOS, JD ;
KAMINSKY, LS .
JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (10) :1054-1059
[7]  
FASCO MJ, 1978, J BIOL CHEM, V253, P7813
[8]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243
[9]   PURIFICATION AND CHARACTERIZATION OF LIVER MICROSOMAL CYTOCHROMES-P-450 - ELECTROPHORETIC, SPECTRAL, CATALYTIC, AND IMMUNOCHEMICAL PROPERTIES AND INDUCIBILITY OF 8 ISOZYMES ISOLATED FROM RATS TREATED WITH PHENOBARBITAL OR BETA-NAPHTHOFLAVONE [J].
GUENGERICH, FP ;
DANNAN, GA ;
WRIGHT, ST ;
MARTIN, MV ;
KAMINSKY, LS .
BIOCHEMISTRY, 1982, 21 (23) :6019-6030
[10]   STABLE ISOTOPE ASSAY FOR PSEUDORACEMIC WARFARIN FROM HUMAN-PLASMA SAMPLES [J].
HOWALD, WN ;
BUSH, ED ;
TRAGER, WF ;
OREILLY, RA ;
MOTLEY, CH .
BIOMEDICAL MASS SPECTROMETRY, 1980, 7 (01) :35-40